Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139620
Status:
COMPLETED
Last Update Posted:
2018-02-08
First Post:
2005-08-25
Brief Title:
A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors With Adequate and Moderately Impaired Hepatic Function
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc
Organization Data
Organization:
Astellas Pharma Inc
Class:
INDUSTRY
Study ID:
OSI-774-104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
OSI Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None